Literature DB >> 11427430

Antibody maturation in Trypanosoma cruzi-infected rats.

I S Marcipar1, M G Risso, A M Silber, S Revelli, A J Marcipar.   

Abstract

The study of antibody avidity changes during infection has improved the understanding of the pathologic processes involved in several infectious diseases. In some infections, like toxoplasmosis, this information is being used for diagnostic purposes. Results of the evolution of antibody avidity for different specific antigens in Trypanosome cruzi-infected rats are presented. A Western blotting technique, combined with avidity analysis to identify antigens that elicit high-avidity antibodies, is suggested. In this system, antibodies showed high avidity values only during the chronic phase of infection and only in relation to antibodies against 21-, 33-, 41-, 42-, 56-, 58-, 66-, and 72-kDa antigens. Finally, a 97-kDa T. cruzi antigen, which was recognized by high-avidity antibodies and occurred in noninfected rats, was identified. These results allow us to evaluate the different antigens in chagasic infection. Our results show that with the correct choice of antigen it is possible to detect differences in maturation of antibodies and to discriminate, in an experimental model, between recent (acute) and chronic infections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427430      PMCID: PMC96146          DOI: 10.1128/CDLI.8.4.802-805.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  23 in total

Review 1.  The molecular and cellular basis of affinity maturation in the antibody response.

Authors:  G J Nossal
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

2.  Antibody avidity following varicella-zoster virus infections.

Authors:  H O Kangro; S Manzoor; D R Harper
Journal:  J Med Virol       Date:  1991-02       Impact factor: 2.327

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Antibody avidity determination by ELISA using thiocyanate elution.

Authors:  G R Pullen; M G Fitzgerald; C S Hosking
Journal:  J Immunol Methods       Date:  1986-01-22       Impact factor: 2.303

5.  Molecular markers in acute and chronic phases of human toxoplasmosis: determination of immunoglobulin G avidity by Western blotting.

Authors:  P T Marcolino; D A Silva; P G Leser; M E Camargo; J R Mineo
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

6.  Differential IgG avidity to rubella virus structural proteins.

Authors:  C A Mauracher; L A Mitchell; A J Tingle
Journal:  J Med Virol       Date:  1992-03       Impact factor: 2.327

7.  Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG.

Authors:  M Lappalainen; P Koskela; M Koskiniemi; P Ammälä; V Hiilesmaa; K Teramo; K O Raivio; J S Remington; K Hedman
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

8.  Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.

Authors:  Y Schlesinger; D M Granoff
Journal:  JAMA       Date:  1992-03-18       Impact factor: 56.272

9.  Recent primary toxoplasma infection indicated by a low avidity of specific IgG.

Authors:  K Hedman; M Lappalainen; I Seppäiä; O Mäkelä
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

10.  Comparison of concentration and avidity of specific antibodies to E. coli in breast milk and serum.

Authors:  F H Sennhauser; R A Macdonald; D M Roberton; C S Hosking
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

View more
  5 in total

1.  Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera.

Authors:  Cristina Riera; Mireia Verges; Laura Iniesta; Roser Fisa; Montserrat Gállego; Silvia Tebar; Montserrat Portús
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection.

Authors:  Sebastián Aguirre; Ariel M Silber; Maria Edileuza F Brito; María E Ribone; Claudia M Lagier; Iván S Marcipar
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

3.  Evaluation of the immune responses induced by four targeted DNA vaccines encoding the juvenile liver fluke antigen, cathepsin B in a mouse model.

Authors:  Rama Jayaraj; David Piedrafita; Terry Spithill; Peter Smooker
Journal:  Genet Vaccines Ther       Date:  2012-08-31

4.  Plasmodium falciparum merozoite surface protein 2: epitope mapping and fine specificity of human antibody response against non-polymorphic domains.

Authors:  Saidou Balam; Sope Olugbile; Catherine Servis; Mahamadou Diakité; Alba D'Alessandro; Geraldine Frank; Remy Moret; Issa Nebie; Marcel Tanner; Ingrid Felger; Thomas Smith; Andrey V Kajava; François Spertini; Giampietro Corradin
Journal:  Malar J       Date:  2014-12-19       Impact factor: 2.979

5.  TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice.

Authors:  Shivali Gupta; Nisha Jain Garg
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.